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BZL,GTN024を添加後,固定・染色し細胞内型虫体数を測
定した.またBZL,GTN024の活性酸素 (ROS)産生を測定
した.【結果・考察】 BZL,GTN024はいずれも細胞内型
原虫に対して抑制効果を示し,IC50値は1.75μM,0.16μM
であった.感染24時間後に化合物を添加すると,BZLでは
抑制効果が見られず,GTN024では細胞内型虫体に抗原虫
作用があることが示唆された.また,HT1080でROS産生
量を測定したところ,両者ともにROS産生が認められた
が,GTN024のROS産生量はBZLの7割程度であった.
以上より,GTN024はBZLとは異なる作用機序を持つこ
とが示唆された.
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The pathogenesis of sarcomatous component in eso-
phageal carcinosarcoma is unclear. To investigate the involvement of epithelial-mesenchymal transition(EMT)in sarcomatous diferentiation,we performed immunohisto-
chemistry for Slug,Twist,ZEB1,and ZEB2,transcription factors associated with EMT and E-cadherin,in 14 cases of SpCC of the esophagus.In order to verify the neoplastic nature of sarcomatous components,TP53 mutation status and protein expression were examined in each case.Nuclear ZEB1 expression was extensive in the sarcomatous compo-
nent,greater than invasive front of carcinoma components
(p＜0.0001).Membranous E-cadherin expression was most-
ly lost in sarcomatous cels in al cases(p＜0.0001).The p53 expression patern was almost concordant between the two areas in al cases.TP53 mutation analysis revealed that 7 cases harbored identical mutations in both components.
One case had mutations only in the sarcomatous component.
It was noteworthy that none of them harbored mutation in exon 5,unlike conventional esophageal squamous cel car-
cinoma.These findings show that ZEB1 are widely expres-
sed in sarcomatous area in esophageal carcinosarcoma,
suggesting the involvement of EMT.The avoidance of exon 5 in terms of TP53 mutation may also be a feature of the
 
tumor.
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【Background】 The role of radioprotective compounds is very important in clinical radiotherapy.Radioprotective compouds should protect normal tissues from both acute and late radiation damage without protecting the cancer tissues. Previous study revealed that 50nM of sodium selenite supplementation on non-cancerous human eso-
phageal cels(CHEK-1 cels)before X-ray irradiation treatment can protect the cels from radiation induced-
damage. However,the efects of sodium selenite sup-
plementation on cancerous cels in X-ray irradiation treat-
ment remain unknown.【Objective】 To investigate the efects of sodium selenite supplementation on cancerous cels with X-ray irradiation treatment.【Methods】
CHEK-1 cels and cancerous human esophageal cels(TE
-8 cels)were cultured in RPMI medium enriched with 10％
fetal bovine serum and 1％ antibiotics(Penicilin and strep-
tomycin).The IC50 of sodium selenite on CHEK-1 and TE
-8 cels was determined by conducting citotoxicity assay.
Cel survival of both cels post 2Gy X-ray irradiation was observed by using cel viability and colony formation assay.
【Results】 The cel IC50 of sodium selenite on CHEK-1 cels was determined to be 3.6μM and 7.4μM on TE-8 cels.
Non-cancerous CHEK-1 cels with 50nM sodium selenite supplementation had a higher survival rate and cel viability at 72h post 2Gy X-ray irradiation compare to the control
(0nM).In contrast,TE-8 cels with 50nM sodium selenite supplementation had a lower survival rate and cel viability at 72h post 2Gy X-ray irradiation compare to control.
【Conclusion】 The results suggest that sodium selenite supplementation at a dose 50nM for 72h before irradiation can protect non-cancerous human esophageal cels but does not protect cancerous esophageal cels from X-ray irradia-
tion treatment.
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